ghk-cu peptide dosing protocol subcutaneous GHK-Cu Dosage and Protocol: A

This investigational peptide mimics the natural hormone amylin (also known as islet amyloid polypeptide or IAPP), which plays a crucial role in glucose homeostasis and satiety regulation [1]

Peptide therapy with DAC is an exception, with a half-life of approximately 68 days, allowing for less frequent dosing

Theoretical synergy exists: cagrilintide reduces caloric intake via satiety prolongation, tesofensine increases caloric expenditure via thermogenesis, and the combination could produce additive weight loss without overlapping side-effect profiles

Retatrutide (Eli Lilly) and CagriSema (Novo Nordisk) represent different approaches to the same goal: achieving weight loss approaching bariatric surgery without the scalpel